Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Nov 11 - Nov 16
glp 1 agonist liraglutide Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study Bestsellers_Bestsellers Purchase Plan:3-Months Supply Role of DPP-4 Inhibitors
Role of DPP-4 Inhibitors in Clinical Practice
The green list includes active pharmaceutical ingredients (APIs) in the GLP-1 drugs that have been inspected by the FDA and are determined to be in compliance with FDA standards
Bestsellers_Bestsellers
Purchase Plan:3-Months Supply
Sodium-glucose transporters (SGLT)-inhibitors The treatment of T2DM with glyflozines, sodium-glucose co-transporter 2 inhibitors, represents a new therapeutic approach ( Among SGLT2 inhibitors, three of them have been approved by the FDA and EMA: canagliflozin (2013), dapagliflozin (2014) and empagliflozin (2014)
US$ 23.92
US$ 24.05
US$ 23.15
US$ 29.48
US$ 24.47
US$ 25.58
US$ 27.42
US$ 22.86
US$ 26.40
US$ 27.93
US$ 27.61
